Shivanagar COVID-19 Hospital, Chitwan, Nepal.
Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
J Nepal Health Res Counc. 2024 Jun 22;22(1):108-113. doi: 10.33314/jnhrc.v22i01.4835.
A series of acute, atypical respiratory diseases was identified in Wuhan, China, which was named Coronavirus disease (COVID-19) by the World Health Organization (WHO), and the disease was later declared a pandemic. This disease has psychological effects in addition to physiological symptoms. This study aims to find out the psychological impacts of disease in the form of anxiety and depressive symptoms among hospitalized patients diagnosed with COVID-19.
A multicentric descriptive cross-sectional study was conducted among patients diagnosed with COVID-19 who were admitted from July 1, 2021 to August 15, 2021 in six different hospitals. Ethical approval was obtained from the Nepal Health Research Council (reference number 284). COVID-19 was diagnosed using Reverse Transcription Polymerase Chain Reaction (RT-PCR) or COVID-19 antigen test. Data were collected from the patients using proforma containing the demographic profile and two questionnaires (Hospital Anxiety and Depression scale and Global Health Questionnaire-12) translated into the Nepali language.
Among 360 patients who participated in the study, 194 (53.9%) were males and 166 (46%) were females. Symptoms of anxiety and depression were seen in 161 (44.7%) and 253 (70.3%) of the participants respectively. Similarly 349 (96.9%) of them were found to have clinically significant mental distress.
The prevalence of anxiety and depressive symptoms among hospitalized patients diagnosed with COVID-19 is significantly high compared to the general population.
中国武汉出现了一系列急性、非典型呼吸道疾病，世界卫生组织（WHO）将其命名为冠状病毒病（COVID-19），随后该疾病被宣布为大流行。除了生理症状外，这种疾病还会对心理产生影响。本研究旨在了解 COVID-19 住院患者中以焦虑和抑郁症状形式出现的疾病的心理影响。
这是一项多中心描述性横断面研究，于 2021 年 7 月 1 日至 2021 年 8 月 15 日期间在六家不同医院对确诊 COVID-19 的患者进行。本研究已获得尼泊尔健康研究委员会的伦理批准（编号 284）。COVID-19 的诊断采用逆转录聚合酶链反应（RT-PCR）或 COVID-19 抗原检测。使用包含人口统计学特征和两份问卷（医院焦虑和抑郁量表和全球健康问卷-12）的表格收集患者数据，问卷已被翻译成尼泊尔语。
在 360 名参与研究的患者中，194 名（53.9%）为男性，166 名（46%）为女性。分别有 161 名（44.7%）和 253 名（70.3%）患者出现焦虑和抑郁症状。同样，有 349 名（96.9%）患者被发现存在临床显著的精神困扰。
与一般人群相比，COVID-19 住院患者中焦虑和抑郁症状的患病率明显较高。
